Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients

Authors :: Boyles, Salynn
Source :: NCI Cancer Weekly. Feb 5, 1990, p18, 1 p.
Publication Year :: 1990
Abstract: Cancer, January 15, 1990; 65(2):200-207. The addition of either prednisone or prednisone and tamoxifen to the drug combination of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) did not appear to increase survival [...]

Subjects :: Cancer -- Adjuvant treatment
Tamoxifen -- Evaluation
Chemotherapy, Combination -- Testing
Women -- Diseases
Prednisone -- Evaluation
Adjuvants, Pharmaceutic -- Evaluation
Breast cancer
Business
Health care industry

Tools